drugset / Trial / NCT05815719

Continuous Double Ovarian Stimulation.

NCT05815719 ↗

Phase 4 Completed 30 enrolled Instituto Bernabeu
Non-randomizedParallel-groupOpen-labelTreatment

Summary

To evaluate the efficacy of the weekly use of corifollitropin alfa in double ovarian stimulation process and to compare it to the conventional protocol with daily medication administration.

Timeline

Start
2022-11-17
Primary completion
2023-04-30
Completion
2023-05-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Corifollitropin alfa Protein / enzyme biologic 150 ug —
Comparator Follitropin Alfa Biosimilar Unknown — —
Comparator Gonal-f Protein / enzyme biologic — —
Comparator Urinary Human follicle stimulating hormone Unknown — —

Indications